Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1078427 | 0.89 | DAO (0.38) | GSTP1SMN1; SMN2DAOSORT1HTR2C | |
| SCHEMBL31485230 | 0.86 | GSTP1 (0.42) | GSTP1TP53SMN1; SMN2HIF1A | |
| SCHEMBL11211634 | 0.81 | GSTP1 (0.45) | GSTP1TP53SMN1; SMN2DAOHIF1A | |
| SCHEMBL1237584 | 0.79 | GSTP1 (0.46) | GSTP1TP53HIF1AMAPT | |
| SCHEMBL6898539 | 0.78 | FNTA (0.39) | GSTP1SMN1; SMN2DAOHTR2C | |
| SCHEMBL6895221 | 0.76 | FNTA (0.35) | GSTP1TP53SMN1; SMN2DAOHIF1A | |
| SCHEMBL1238429 | 0.76 | GSTP1 (0.44) | GSTP1TP53DAOHIF1AMAPT | |
| SCHEMBL278013 | 0.75 | GSTP1 (0.42) | GSTP1TP53HIF1AMAPT | |
| SCHEMBL1235894 | 0.74 | GSTP1 (0.43) | GSTP1TP53 | |
| SCHEMBL743966 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3826986-B1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2026-03-04 | — | — | EP | disclosed |
| CN-117986090-A | Novel fragrances with rose scent | 西姆莱斯股份公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-112469685-B | Novel fragrances with rose scent | 西姆莱斯股份公司 | 2024-01-02 | — | — | CN | disclosed |
| US-11634659-B2 | Fragrances with rose scent | SYMRISE AG (DE) | 2023-04-25 | — | — | US | disclosed |
| US-20210324300-A1 | NOVEL FRAGRANCES WITH ROSE SCENT | SYMRISE AG (DE) | 2021-10-21 | — | — | US | disclosed |
| EP-3826986-A1 | NOVEL ODORANTS HAVING ROSE ODOUR | Symrise AG (DE) | 2021-06-02 | — | — | EP | disclosed |
| CN-112469685-A | Novel flavoring agent with rose smell | 西姆莱斯股份公司 | 2021-03-09 | — | — | CN | disclosed |
| WO-2020020434-A1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2020-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11634659-B2 | Fragrances with rose scent | NR1H2, DUOX2, AOX1 | GSTP1 905/4885TP53 1912/4885SMN1; SMN2 4131/4885 |
| US-20210324300-A1 | NOVEL FRAGRANCES WITH ROSE SCENT | NR1H2, DUOX2, AOX1 | GSTP1 887/4885TP53 1820/4885SMN1; SMN2 3983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.